…
L'Oréal S.A., through its subsidiaries, manufactures and sells cosmetic products for women and men in Europe, North America, North Asia, South Asia Pacific, the Middle East, North Africa, Sub-Saharan Africa, and Latin America. It operates through four divisions: Professional Products, Consumer Products, Luxe, and Dermatological Beauty. The company offers skincare, make-up, hair colourant, haircare, perfume, and hygiene products. It provides its products under the L'Oréal Paris, Garnier, Maybelline New York, NYX Professional Makeup, Stylenanda, Essie, Dark & Lovely, Mixa, Niely, L'Oréal Professionnel, Kérastase, Redken, Matrix, Pureology, Lancôme, Yves Saint Laurent Beauté, Armani Beauty, Kiehl's, Helena Rubinstein, Aesop, Biotherm, Valentino, Prada, Shu Uemura, IT Cosmetics, Mugler, Ralph Lauren, Urban Decay, Azzaro, Maison Margiela, Viktor&Rolf, Takami, La RochePosay, CeraVe, Vichy, SkinCeuticals, Skinbetter Science, and other brand names. The company sells its products through distribution channels, such as hair salons, local stores, e-commerce, travel retail, mass market retail, department store perfumeries, pharmacies, drug stores, medi-spas, and free-standing stores. L'Oréal S.A. was founded in 1909 and is headquartered in Clichy, France.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
L'Oreal CDR (CAD Hedged) gives Canadian investors exposure to L'Oréal S.A., a global cosmetics and personal-care company selling skincare, haircare, makeup and fragrance across mass to luxury channels. Long-term growth drivers include product innovation, emerging-market expansion, premiumization and e-commerce growth; the CAD-hedged structure may reduce currency volatility for Canadian holders. Its diversified brand portfolio and global scale appears positioned to support resilient cash generation.
Investors should monitor sensitivity to consumer discretionary spending and shifting beauty trends, intensifying competition from niche and direct-to-consumer brands, and regulatory or supply-chain disruptions.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 8502.20M | 8432.90M | 8001.00M | 7610.60M | 6046.90M |
| Minority interest | -6.50M | -7.80M | -6.50M | -6.00M | -5.10M |
| Net income | 6127.20M | 6408.70M | 6184.10M | 5706.60M | 4597.10M |
| Selling general administrative | 22466.10M | 22217.40M | 20963.90M | 18967.60M | 16665.20M |
| Gross profit | 32738.60M | 32259.80M | 30415.50M | 27683.20M | 23854.30M |
| Reconciled depreciation | 1817.40M | 1855.30M | 1715.00M | 1536.10M | 1781.00M |
| Operating income | 8891.90M | 8249.80M | 7693.40M | 7215.40M | 6160.40M |
| Interest expense | 374.80M | 0.30M | 31.40M | 90.60M | 48.10M |
| Tax provision | 2363.10M | 2015.10M | 1810.60M | 1899.40M | 1445.40M |
| Interest income | 167.70M | 219.80M | 356.30M | 467.60M | 18.50M |
| Net interest income | -236.10M | -261.40M | -113.40M | -72.90M | -59.70M |
| Total revenue | 44052.00M | 43486.80M | 41182.50M | 38260.60M | 32287.60M |
| Total operating expenses | 35160.10M | 35237.00M | 33489.10M | 31045.20M | 26127.20M |
| Cost of revenue | 11313.40M | 11227.00M | 10767.00M | 10577.40M | 8433.30M |
| Net income from continuing ops | 6133.70M | 6416.50M | 6190.50M | 5712.60M | 4602.20M |
| Net income applicable to common shares | - | 6408.70M | 6184.00M | 5706.60M | - |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 61821.20M | 56353.40M | 51855.10M | 46844.20M | 43013.40M |
| Intangible assets | 5072.00M | 4594.80M | 4287.10M | 3640.10M | 3462.70M |
| Other current assets | 547.30M | 585.30M | 539.60M | 2423.10M | 754.00M |
| Total liab | 26817.40M | 23215.60M | 22773.50M | 19657.70M | 19420.80M |
| Total stockholder equity | 34953.20M | 33133.30M | 29074.30M | 27178.50M | 23585.70M |
| Other current liab | 394.70M | 375.20M | 420.80M | 4484.40M | 399.00M |
| Common stock | - | 106.90M | 106.90M | 107.00M | - |
| Capital stock | 106.80M | 106.90M | 106.90M | 107.00M | 111.50M |
| Retained earnings | 6127.20M | 6408.70M | 6184.00M | 5706.60M | 4597.10M |
| Good will | 14469.70M | 13382.00M | 13102.60M | 11717.70M | 11074.50M |
| Other assets | - | 1444.70M | 1250.70M | 1201.20M | - |
| Cash | 9865.00M | 4052.30M | 4288.10M | 2617.70M | 2713.80M |
| Cash and equivalents | - | 1829.30M | 624.10M | 718.50M | - |
| Total current liabilities | 15366.50M | 14636.00M | 14899.70M | 13719.60M | 16583.20M |
| Net debt | 253.70M | 2516.10M | 2549.90M | 1412.70M | 1916.30M |
| Short term debt | - | 36.30M | 67.00M | 876.90M | - |
| Short long term debt | 2048.90M | 1381.30M | 2091.40M | 1012.80M | 4619.40M |
| Other stockholder equity | - | 7028.60M | 5614.10M | 6320.60M | - |
| Property plant equipment | - | 5965.20M | 5560.10M | 4964.40M | - |
| Total current assets | 22198.50M | 16473.50M | 16325.40M | 14049.60M | 12075.80M |
| Short term investments | 31.20M | 29.10M | 33.10M | 23.10M | 4.80M |
| Net receivables | 5500.30M | 5601.80M | 5092.70M | 4755.50M | 4021.00M |
| Long term debt | 8069.80M | 5187.10M | 4746.60M | 3017.60M | 10.70M |
| Inventory | 4543.30M | 4630.10M | 4482.40M | 4079.40M | 3166.90M |
| Accounts payable | 6727.70M | 6468.50M | 6347.00M | 6345.60M | 6068.10M |
| Non currrent assets other | 540.80M | 471.40M | 329.40M | 399.90M | 0.10M |
| Non current assets total | 39622.70M | 39879.90M | 35529.70M | 32794.50M | 30937.60M |
| Capital lease obligations | 1797.40M | 1926.60M | 1854.00M | 1620.50M | 1670.30M |
| Long term debt total | - | 6645.10M | 6140.90M | 4231.10M | - |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | 2509.00M | -1927.00M | -170.70M | -142.80M | -117.30M |
| Total cashflows from investing activities | - | -3703.90M | -4143.70M | -2223.80M | - |
| Net borrowings | 3425.00M | -254.40M | 2743.40M | -543.90M | 3939.40M |
| Total cash from financing activities | - | -4785.10M | -1614.60M | -4079.90M | - |
| Net income | 6127.20M | 6408.70M | 6184.00M | 5706.60M | 4597.10M |
| Change in cash | 5812.80M | -235.80M | 1670.40M | -96.10M | -3692.10M |
| Begin period cash flow | 4052.30M | 4288.10M | 2617.70M | 2713.80M | 6405.90M |
| End period cash flow | 9865.00M | 4052.30M | 4288.10M | 2617.70M | 2713.80M |
| Total cash from operating activities | 8656.90M | 8286.00M | 7604.60M | 6278.30M | 6728.40M |
| Issuance of capital stock | 65.60M | 69.90M | 1.50M | 103.20M | 5.80M |
| Depreciation | 1817.40M | 1855.30M | 1715.00M | 1536.10M | 1781.00M |
| Other cashflows from investing activities | - | -2062.20M | -2655.00M | -880.60M | - |
| Dividends paid | -3917.00M | 3614.90M | 3425.60M | 2689.90M | 2352.10M |
| Change to inventory | -141.90M | -121.20M | -438.30M | -865.40M | -373.30M |
| Sale purchase of stock | -501.50M | -427.60M | -503.30M | -502.30M | -10060.90M |
| Other cashflows from financing activities | - | -13.90M | 0.00M | -0.10M | - |
| Capital expenditures | 1495.30M | 1641.70M | 1488.70M | 1343.20M | 1075.20M |
| Change in working capital | 327.40M | -226.70M | -394.90M | -1011.30M | 87.90M |
| Stock based compensation | 248.30M | 239.10M | 168.50M | 169.00M | 155.20M |
| Other non cash items | 17.40M | 21.10M | 14.10M | -38.70M | 16.50M |
| Free cash flow | 7161.60M | 6644.30M | 6115.90M | 4935.10M | 5653.20M |
|
Stock Name
|
Change
(CAD) |
Price
(CAD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| LORL L'Oreal CDR (CAD Hedged) |
- -% |
28.50 | 1.26 | 1.06 | 0.17 | 0.22 | 4.30 | 17.71 |
| AVGO Broadcom CDR (CAD Hedged) |
-0.24 1.95% |
12.35 | 12.44 | 5.73 | 4.54 | 3.78 | 28.65 | 52.40 |
| WMT Walmart CDR (CAD Hedged) |
2.30 4.43% |
54.19 | 45.06 | 41.67 | 1.38 | 9.84 | 1.51 | 23.16 |
| LLY Eli Lilly CDR (CAD Hedged) |
0.38 0.76% |
50.60 | 37.91 | 25.77 | 12.03 | 29.35 | 12.92 | 26.57 |
| JPM JPMorgan CDR (CAD Hedged) |
1.61 3.76% |
44.45 | 14.46 | 14.03 | 4.49 | 2.36 | 6.97 | - |
L'Oréal S.A., through its subsidiaries, manufactures and sells cosmetic products for women and men in Europe, North America, North Asia, South Asia Pacific, the Middle East, North Africa, Sub-Saharan Africa, and Latin America. It operates through four divisions: Professional Products, Consumer Products, Luxe, and Dermatological Beauty. The company offers skincare, make-up, hair colourant, haircare, perfume, and hygiene products. It provides its products under the L'Oréal Paris, Garnier, Maybelline New York, NYX Professional Makeup, Stylenanda, Essie, Dark & Lovely, Mixa, Niely, L'Oréal Professionnel, Kérastase, Redken, Matrix, Pureology, Lancôme, Yves Saint Laurent Beauté, Armani Beauty, Kiehl's, Helena Rubinstein, Aesop, Biotherm, Valentino, Prada, Shu Uemura, IT Cosmetics, Mugler, Ralph Lauren, Urban Decay, Azzaro, Maison Margiela, Viktor&Rolf, Takami, La RochePosay, CeraVe, Vichy, SkinCeuticals, Skinbetter Science, and other brand names. The company sells its products through distribution channels, such as hair salons, local stores, e-commerce, travel retail, mass market retail, department store perfumeries, pharmacies, drug stores, medi-spas, and free-standing stores. L'Oréal S.A. was founded in 1909 and is headquartered in Clichy, France.
| Name | Title | Year Born |
|---|---|---|
| Mr. Nicolas Hieronimus | CEO & Director | 1964 |
| Mr. Christophe Babule | Executive VP & CFO | 1965 |
| Mr. Antoine Vanlaeys | Chief Operations Officer | 1969 |
| Ms. Eva Quiroga-Thiele | Head of Investor Relations | NA |
| Ms. Asmita Dubey | Chief Digital & Marketing Officer | 1974 |
| Mr. Jean-Claude Le Grand | Chief Human Relations Officer | 1965 |
| Mr. Vismay Sharma | President of South Asia Pacific, Middle East, North Africa Zones | 1972 |
| Mr. Jacques Challes | Chief Innovation Officer | 1960 |
| Emmanuel Goulin | President of Travel Retail | 1977 |
| Ms. Barbara Lavernos | Deputy Chief Executive Officer | 1968 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.